Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONCERT-2: Panitumumab vs Chemoradiotherapy in SCCHN
NCT00547157Phase 2Completed
- Sponsor
- Amgen
- Start
- Nov 2007
- Primary completion
- Dec 2011
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of panitumumab in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Amgen. Started Nov 2007; status: completed.
02
Drugs
panitumumab
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00547157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00547157.